These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 26456885)

  • 1. Moderate concordance was found between case-only and parallel group designs in systematic comparison.
    Pouwels KB; Mulder B; Hak E
    J Clin Epidemiol; 2016 Mar; 71():18-24. PubMed ID: 26456885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-controlled designs in pharmacoepidemiology involving electronic healthcare databases: a systematic review.
    Gault N; Castañeda-Sanabria J; De Rycke Y; Guillo S; Foulon S; Tubach F
    BMC Med Res Methodol; 2017 Feb; 17(1):25. PubMed ID: 28178924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect estimate comparison between the prescription sequence symmetry analysis (PSSA) and parallel group study designs: A systematic review.
    Idema DL; Wang Y; Biehl M; Horvatovich PL; Hak E
    PLoS One; 2018; 13(12):e0208389. PubMed ID: 30521568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. When should case-only designs be used for safety monitoring of medical products?
    Maclure M; Fireman B; Nelson JC; Hua W; Shoaibi A; Paredes A; Madigan D
    Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():50-61. PubMed ID: 22262593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence from crossover trials: empirical evaluation and comparison against parallel arm trials.
    Lathyris DN; Trikalinos TA; Ioannidis JP
    Int J Epidemiol; 2007 Apr; 36(2):422-30. PubMed ID: 17301102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crossover versus parallel designs: dose-escalation design comparisons for first-in-human studies.
    Yan Z; Hosmane B; Locke C
    J Biopharm Stat; 2013; 23(4):804-17. PubMed ID: 23786490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods in epidemiology: observational study designs.
    DiPietro NA
    Pharmacotherapy; 2010 Oct; 30(10):973-84. PubMed ID: 20874034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case-only designs in pharmacoepidemiology: a systematic review.
    Nordmann S; Biard L; Ravaud P; Esposito-Farèse M; Tubach F
    PLoS One; 2012; 7(11):e49444. PubMed ID: 23166668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of instrumental variable methods in cohort and nested case-control studies: a simulation study.
    Uddin MJ; Groenwold RH; de Boer A; Belitser SV; Roes KC; Hoes AW; Klungel OH
    Pharmacoepidemiol Drug Saf; 2014 Feb; 23(2):165-77. PubMed ID: 24306965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hybrid designs in studies].
    Mandiracioğlu A
    Turkiye Parazitol Derg; 2009; 33(3):227-31. PubMed ID: 19851970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical approaches for design and analysis of clinical trials of infertility treatments: crossover designs and the Mantel-Haenszel method are recommended.
    Takada M; Sozu T; Sato T
    Pharm Stat; 2015; 14(3):198-204. PubMed ID: 25776032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between pacifier use and breast-feeding, sudden infant death syndrome, infection and dental malocclusion.
    Callaghan A; Kendall G; Lock C; Mahony A; Payne J; Verrier L
    Int J Evid Based Healthc; 2005 Jul; 3(6):147-67. PubMed ID: 21631747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled corticosteroids in children with persistent asthma: effects on growth.
    Zhang L; Prietsch SO; Ducharme FM
    Evid Based Child Health; 2014 Dec; 9(4):829-930. PubMed ID: 25504972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of studies of treatments for hand eczema-the EDEN hand eczema survey.
    Van Coevorden AM; Coenraads PJ; Svensson A; Bavinck JN; Diepgen TL; Naldi L; Elsner P; Williams HC;
    Br J Dermatol; 2004 Aug; 151(2):446-51. PubMed ID: 15327553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Four different study designs to evaluate vaccine safety were equally validated with contrasting limitations.
    Glanz JM; McClure DL; Xu S; Hambidge SJ; Lee M; Kolczak MS; Kleinman K; Mullooly JP; France EK
    J Clin Epidemiol; 2006 Aug; 59(8):808-18. PubMed ID: 16828674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing trial efficiency by early reallocation of placebo nonresponders in sequential parallel comparison designs: application to antidepressant trials.
    Boessen R; Knol MJ; Groenwold RH; Grobbee DE; Roes KC
    Clin Trials; 2012 Oct; 9(5):578-87. PubMed ID: 23060319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The place of the crossover design in infertility trials: a maximum likelihood approach.
    McDonnell J; Goverde AJ; Vermeiden JP
    Hum Reprod; 2004 Nov; 19(11):2537-44. PubMed ID: 15459169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and analysis of crossover trials for absorbing binary endpoints.
    Nason M; Follmann D
    Biometrics; 2010 Sep; 66(3):958-65. PubMed ID: 19930189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal and efficient crossover designs under different assumptions about the carryover effects.
    Hedayat AS; Stufken J
    J Biopharm Stat; 2003 Aug; 13(3):519-28. PubMed ID: 12921398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of interventions that assist caregivers to support people with dementia living in the community: a systematic review.
    Parker D; Mills S; Abbey J
    Int J Evid Based Healthc; 2008 Jun; 6(2):137-72. PubMed ID: 21631819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.